Related Experiment Videos
Interaction of rifampin and digitoxin.
Archives of Internal Medicine
|March 1, 1983
Summary
Rifampin significantly reduces digitoxin levels in patients. Discontinuing rifampin therapy allows digitoxin levels to return to normal, highlighting a critical drug interaction.
Area of Science:
- Pharmacology
- Drug Interactions
- Clinical Therapeutics
Background:
- Digitoxin is a cardiac glycoside used for heart failure.
- Drug-drug interactions can alter medication efficacy and safety.
Observation:
- A patient on digitoxin therapy experienced a significant drop in serum digitoxin levels.
- This decrease coincided with the initiation of rifampin treatment.
Findings:
- Rifampin administration markedly decreased serum digitoxin concentrations.
- Discontinuation of rifampin therapy resulted in the restoration of pretreatment digitoxin levels.
Implications:
- Clinicians should monitor digitoxin levels when initiating or discontinuing rifampin.
- This interaction necessitates careful management in patients receiving both medications.